Digestive Health

The launch marks Ferring’s second treatment this month specified for Crohn disease.

Prepare to counsel patients on microbiome-related products.

Pharmacists continue to report famotidine shortages following ranitidine recalls and a recent report suggesting use in COVID-19.

Pharmacists can counsel patients with GERD on strategies to address their symptoms.

Type 2 diabetes risk prediction is improved by observing changes in gut bacteria, a study finds.

Pharmacists can and must play an active role in guiding patients on the selection of laxatives which are supported by sound evidence.

Though the relationship between genetics and gut-dwelling bacteria is still a realm of mystery, new research has begun a new step towards better understanding how one affects the other.

The first and only one of its kind, metoclopramide nasal spray offers relief to often debilitating symptoms of the gastrointestinal disease.

IW-3718, an investigational adjunct therapy to proton pump inhibitors for refractory GERD, showed favorable results in reducing heartburn severity and other symptoms.